GSK, led by boss Luke Miels, pictured, said it will be closing down its R&D site in Stevenage, Hertfordshire, and moving its staff to a new facility in Cambridge.
Calum Muirhead is the Executive Editor at Financial Mail on Sunday. He covers a diverse range of topics within finance and investment, including alternative investments, asset management, and wealth management, while also exploring themes in healthcare and real estate. Calum's insights and analyses have been featured in notable publications such as The Business Herald, MSN, Express Digest, This Is Money, and the Daily Mail.











